KIR3DL1 and type 1 diabetes mellitus: Considering the activating KIR2DL1 with ligand A*24:02 (Fig. 1c), carriers of the HLA-I allele without KIR showed no progression to type 1 diabetes but those who carried the interaction experienced an incidence comparable with that in the two other groups.